Monopost®

Preservative Free Eye drops solution in single-dose container for the reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension.

Monopost

The first and only preservative-free latanoprost, Monopost removes the risk of ocular surface problems that have been reported to be caused by long-term preservative containing eye drops.

Monopost has been shown to provide non-inferior IntraOcular Pressure (IOP) control compared to Xalatan with statistically significantly lower hyperaemia and symptoms on instillation.1

Studies where patients have been switched from preserved to preservative-free latanoprost (Monopost) have demonstrated reductions in the frequency and severity of hyperaemia and other symptoms.2

Rouland, J.F. et al. Br J Ophthalmol. 2013;97(2):196-200
Misiuk-Hojło, M. et al. EVER 2014 congress. Poster #T018

Related Files

Adverse events should be reported. Reporting forms are available and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should be reported to Thea Pharmaceuticals Ltd

Contact Us

Is there anything we can help you with? From requesting a product sample, arranging a visit from one of our helpful customer representatives, or simply asking us a question about Thea Pharmaceuticals products. Use the form and we'll be in touch as soon as possible.

Fields indicated with * are required

Form Icon